- Celebrity news
- Fundraising news
- Policy news
- Science news
For the last two years, Paul, more popularly known in the gaming world as TheRunningManZ, has completed two sponsored 16-hour live gaming streams raising money for Alzheimer’s Research UK
A team of scientists in the US have found that people who had heart conditions in middle-age were more likely to have memory and thinking problems in later life.
Celebrated photographer Bunshri Chandaria is launching Silent Voice, an artist book which depicts a photographic exploration of dementia.
The NEC Group has announced that its fundraising efforts for 2023 will be for Alzheimer’s Research UK, the UK’s leading dementia research charity.
Research published today (Wednesday 25 January) in The BMJ found that people in their 60s who lead a healthier lifestyle experience slower cognitive decline.
Alzheimer’s Research UK welcomes new Government commitments to increase healthy life expectancy and reduce ill-health in the UK, as part of its new Major Conditions Strategy.
The UK’s leading dementia research charity wants to empower people to look after their brains and reduce their risk of dementia in later life, with the help of The Think Brain Health Check-in.
Retailer The Perfume Shop has passed the incredible milestone of raising £1 million for Alzheimer’s Research UK.
It’s been less than two years since the US Food and Drug Administration (FDA) approved the first licence of a new drug for Alzheimer’s disease in a generation. But that drug, aducanemab, became a source of controversy, and was not approved for use in Europe by the European Medicines Agency (EMA). Now, the US regulator…
Alzheimer’s Research UK is offering people from South Asian communities in Leicester the opportunity to sign up to become Dementia Community Champions, to help build awareness and understanding around the condition.
Launching a report on air pollution, England’s Chief Medical Officer Sir Chris Whitty, has warned of the growing body of evidence linking poor air quality and an increased risk of developing dementia in later life.
New research suggests that the use of hearing aids and cochlear implants can reduce the risk of developing dementia by slowing down cognitive decline, such as memory loss.
Today (Wednesday 30 November) at the Clinical Trials on Alzheimer’s Disease Conference in San Francisco, the pharmaceutical company, Eisai, reports full data from its successful phase 3 clinical trial of the Alzheimer’s drug, lecanemab.
Dan Jones from Norwich has won an award for his commitment to supporting life-changing dementia research.
Loughborough RAG has won an award for its commitment to supporting life-changing dementia research.
Alzheimer’s Research UK ‘delighted’ by Government’s recommitment to Dame Barbara Windsor Dementia Mission to accelerate new treatments
The Government’s recommitment to delivering the Dame Barbara Windsor Dementia Mission has been warmly welcomed by Alzheimer’s Research UK, the UK’s leading dementia research charity.
Fred Walker from Sale has been recognised for his commitment to supporting life-changing dementia research with a fitting accolade.
Researchers based in Chicago looked at the effects of antioxidants called flavonols on brain health in later life.
The pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer’s drug gantenerumab did not achieve the goal of slowing clinical decline in participants with early Alzheimer’s disease.
The ALBORADA Drug Discovery Institute (ADDI) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that cause dementia.
Cambridgeshire-based charity, Alzheimer’s Research UK, has again been recognised as one of the Best Companies to work for in the East of England.
Experienced Global Pharma Industry Leader, Prof Fiona Randall, joins the Alzheimer’s Research UK UCL Drug Discovery Institute as Chief Scientific Officer
Prof Fiona Randall has been appointed as Chief Scientific Officer (CSO) for Alzheimer’s Research UK’s University College London Drug Discovery Institute (UCL DDI)
Researchers in Canada have carried out a review of existing evidence of a link between dementia and air pollution.
OddBalls has partnered with Alzheimer’s Research UK to release a limited-edition range of underwear, in an effort to raise vital funds for the charity.
In November, Nicholas Lyons, Director at London-based specialty insurer, Convex, will become the new Lord Mayor of London. To celebrate his appointment at the annual Lord Mayor’s Show on 12 November, Convex has donated a float to its charity partner, Alzheimer’s Research UK.